Boston Scientific Corp
NYSE: BSX
$83.92
+$0.21 (+0.3%)
Closing Price on September 20, 2024
BSX Articles
According to Reuters, Dell (DELL) will restate four years of results after an audit that lasted over a year. Reuters writes that Bear Steans (BSC) will cut 240 jobs in its sub-prime operations....
Published:
The current version of Boston Scientific (BSX) is a merged compeny. The former Guidant sales are the heart rhythm managment operations of the new company. Heart stent sales come from the old BSX. The...
Published:
Boston Scientific (BSX) had planned to take its fast-growing endosurgery group public to raise as much as $1 billion. According to The Associated Press: "The endosurgery unit has recently enjoyed...
Published:
According to Reuters, net income at Toyota (TM) rose sharply on strong US and European sales. Reuters writes that American Home Mortgage (AHM) will close today and lay-off all of its employees. The...
Published:
Amgen (AMGN) actually rallied a bit after hours yesterday. But, revenue growth was hard to come by. Amgen reported net income of $1.02 billion, or 90 cents per share, for the quarter ended June 30,...
Published:
A large drop in the sale of drug coated stents knocked Boston Scientific’s (BSX) quarter way down. The company’s second-quarter profit, excluding charges, was $271 million, or 18 cents per share,...
Published:
Boston Scienfitic (BSX) has a deal to "settle all pending federal lawsuits against the company alleging harm from faulty defibrillators and pacemakers for $195 million," according to The Wall Street...
Published:
THURSDAYAdvanced Micro Devices (NYSDAQ:AMD)Ameritrade (NASDAQ:AMTD)Bank of America (NYSE:BAC)Bank of New York (NYSE:BK)Cemex (NYSE:CX/ADR)Continental Airlines (NYSE:CAL)Cypress Semi (NYSE:CY)Dow...
Published:
According to Reuters, Australia Australian fund manager Caledonia said it would vote against Chicago Merch’s (CME) proposal to buy CBOT (CBOT) The fund own over 6% off the exchange. Reuters writes...
Published:
As you will see, the short interest changes in medical and drug stocks of the active NYSE-listed names was a bit of a mixed bag. GlaxoSmithkline (GSK) saw the lagest increase, but its short...
Published:
Some sectors showed mixed results in the short selling, but the Big Pharma and medical instruments and related companies saw an increased activity in short selling in May versus April. Below is the...
Published: